Perinatal Psychiatric Medication Shared Decision / 围产期精神科用药共同决策

Definition

Perinatal psychiatric medication shared decision is the boundary that pregnancy and breastfeeding treatment choices must be individualized with qualified clinicians rather than reduced to “all medicine is unsafe” or “breastfeeding must always continue.”

Current Synthesis

The source frames medicine, pregnancy, breastfeeding, and infant exposure as a risk-balancing conversation. Relevant questions include the specific medicine and dose, pharmacokinetics and milk transfer, gestational or postpartum context, the severity and recurrence risk of maternal illness, possible fetal or infant effects, feeding goals, stored milk, and whether temporary or sustained feeding changes are being considered. The patient should be able to state fears and preferences, receive clear risk explanation, and participate in the decision.

The synthesis does not supply a drug list or a universal answer. It establishes a process boundary: neither abrupt self-discontinuation nor blanket avoidance is supported, and untreated serious illness also belongs in the risk calculation.

Key Claims

• Pregnancy and lactation decisions depend on the specific medicine, exposure pathway, timing, dose, illness, and patient context.
• Milk transfer and fetal risk cannot be inferred from the broad label “antidepressant.”
• Maternal illness severity and the risks of non-treatment belong in the same decision as possible fetal or infant exposure.
• Continuing medicine, changing medicine, changing feeding, using stored milk, or stopping breastfeeding are distinct choices rather than one automatic package.
• The patient should voice concerns and preferences while clinicians explain known risks, uncertainties, and alternatives.
• Medication should not be started, changed, or stopped from podcast guidance alone.

Evidence

• Medicine-specific assessment - VOL.71精神科｜关爱产后抑郁：产前一级预防 产后拒绝漠视 给予更多陪伴 says lactation decisions depend on the medicine’s category and pharmacokinetics rather than a blanket prohibition.
• Choice structure - VOL.71精神科｜关爱产后抑郁：产前一级预防 产后拒绝漠视 给予更多陪伴 distinguishes medication use, breastfeeding continuation, temporary or sustained feeding change, and stored milk.
• Shared decision process - VOL.71精神科｜关爱产后抑郁：产前一级预防 产后拒绝漠视 给予更多陪伴 asks patients to express concerns and clinicians to provide risk information before a joint decision.

Counterevidence & Qualifications

The source names no medicines, doses, trimester-specific risks, infant-monitoring plan, comparative evidence, or emergency protocol. It therefore cannot determine whether a particular person should take, switch, taper, or stop a medicine or alter feeding. Obstetric, psychiatric, pediatric, primary-care, and lactation expertise may all be relevant, especially when illness is severe or safety is uncertain.

What Changed

• Created a perinatal decision boundary that places medicine exposure, untreated illness, feeding preferences, and clinician risk communication in one process.

Related Concepts

• Postpartum Depression Recognition and Support / 产后抑郁识别与支持 - clinical context in which treatment decisions may arise.
• Perinatal Mental-Health Prevention / 围产期心理健康预防 - earlier planning and screening context.
• Psychiatric Medication Supervision Boundary - broader rule against unsupervised psychiatric medication changes.
• Doctor-Patient Communication - mechanism for expressing concern and receiving understandable risk information.
• Medical Risk Management - broader framework for balancing multiple uncertain harms.